Bob Shepard

Bob Shepard

| This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Specialist, UAB News
(205) 934-8934 
bshep@uab.edu

A 16-year veteran of UAB, Shepard previously had a career in television news, serving as a photographer, field producer and documentary producer at stations in Lexington, Ky.; Norfolk, Va.; and Birmingham. He spends a fair amount of free time canoeing the rivers of the southern Appalachians and believes that his beloved Chicago Cubs will win the World Series this year. Finally.

Beats include: Callahan Eye Foundation Hospital; Center for Aging; Center for Palliative Care; Comprehensive Neuroscience Center; Emergency Medicine; Gene Therapy Center; Gerontology, Geriatrics and Palliative Care; Gregory F. James Cystic Fibrosis Center; Heflin Genetics Center; Nutrition Sciences; School of Health Professions; School of Medicine; Trauma, Burn and Surgical Critical Care
Patients with rheumatoid arthritis have an increased risk for shingles, but new research at UAB indicates that biologics – the newest RA medications – don’t worsen that risk.
The Mike L. Jezdimir Transverse Myelitis Foundation supports TM research at UAB in eight disciplines.
A UAB medical student discovered a previously uncategorized sub-group of patients with type 2 diabetes that might bring about changes in clinical practice.
Researchers say ketamine appears to work on depression by blocking the neurotransmitter glutamate from binding to the NMDA receptor on neurons.
A UAB research team has discovered a new pathway that contributes to fibrosis, or scarring in the lungs.
The public debate, “High vs. Low Carbohydrate Diets for Cancer Control and Overall Health,” will take place  from 5 p.m. to 6:30 p.m. March 27 at the UAB Alumni House.
Kenneth Saag, M.D., co-authored a review of five tests and treatments used in rheumatology that should be questioned and discussed between doctors and patients.
UAB scientists published 92 papers in the field of rehabilitation science from 2005 to 2009.
The therapy, approved for use in parts of Europe and Israel, is undergoing investigation in the United States as a potential method of reducing lung volume in patients with severe emphysema.
Finley, a professor emeritus at UAB, was co-director of the Laboratory of Medical Genetics for 30 years.